Johns Hopkins Scientists Develop Nasal DNA Vaccine for Tuberculosis

11 hours ago 18

Rommie Analytics

Artist’s Illustration of Tuberculosis BacteriaA new experimental vaccine takes aim at one of tuberculosis’s most stubborn defenses: the ability of bacteria to persist despite treatment. In a study published in the Journal of Clinical Investigation, researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health report developing a therapeutic DNA vaccine delivered through the nose [...]
Read Entire Article